USE OF HYALURONIDASE FOR PREVENTING AND TREATING CARDIO VASCULAR DISEASES

摘要

The invention relates to the use of the enzyme hyaluronidase in a dosage of at least 6000 units per day for preventing and/or treating cardiovascular diseases. The hyaluronidase is administrated intravenously over a period of at least four weeks. Hyaluronidase is especially suitable for treating coronary heart disease and for prevention in patients at risk of cardiac infarction.